# FDA Inspection 1137406 - Rachel E. Sanborn, M.D. - February 24, 2021

Source: https://www.keypedia.com/records/fda_inspections/rachel-e-sanborn-md/5117b8b0-d24f-4f5e-ab28-a6491e616fea
Source feed: FDA_Inspections

> FDA Inspection 1137406 for Rachel E. Sanborn, M.D. on February 24, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1137406
- Company Name: Rachel E. Sanborn, M.D.
- Inspection Date: 2021-02-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/rachel-e-sanborn-md/c20d844c-99c2-4964-8a22-51e3fe80454e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c